This brand name is authorized in Ecuador
The drug LEMBIRAX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Clidinium
UNII 91ZQW5JF1Z - CLIDINIUM BROMIDE
|
|
Clidinium is a synthetic anticholinergic that has a spasmolytic effect on smooth muscle and also inhibits secretions. |
|
2
Chlordiazepoxide
UNII MFM6K1XWDK - CHLORDIAZEPOXIDE HYDROCHLORIDE
|
|
Chlordiazepoxide has anxiolytic and central muscle relaxant properties. It has little autonomic activity. Chlordiazepoxide acts as depressant of the central nervous system producing all levels of CNS depression, from mild sedation to hypnosis, to coma depending on the dose. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A03CA02 | Clidinium and psycholeptics | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03C Antispasmodics in combination with psycholeptics → A03CA Synthetic anticholinergic agents in combination with psycholeptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 4.975-3-07-03 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
